Equity Markets: Is It Time to Worry?
Orthopedic investors are prioritizing later-stage companies with a clear path to commercialization and profitability....
Orthopedic investors are prioritizing later-stage companies with a clear path to commercialization and profitability....
Manufactured with 3D-printed titanium, the NanoHive interbody portfolio spans anterior and posterior lumbar, as well as cervical applications....
The orthopedic market will finish 2023 with significantly elevated growth rates compared to its historical norms....
Among transition plans, President/COO Brady R. Shirley will assume the role of Executive Advisor in early 2024 and will retire...
Over 3 million Aetna Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis pain....
Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now....
GPS Ankle connects the preoperative plan with real-time intraoperative instrument guidance and confirms that resections meet the surgical plan....
Novadip is developing a new class of regenerative tissue products to accelerate healing of large bone defects and injuries in...
Vyrsa manufactures and supports a complete portfolio of FDA-cleared sacroiliac joint fusion devices....
Analysis at 42% enrollment showed sustained improvement in clinical efficacy and safety endpoints vs. 3-months evaluations....
Login
Register for a free account
As a guest member you get access to more articles and videos every month.